Abstract:BACKGROUND: Cancer cells selectively promote the translation of oncogenic transcripts to stimulate cancer progression. Although growing evidence has revealed that tRNA modifications and related genes participate in this process, their roles in head and neck squamous cell carcinoma (HNSCC) remain largely uncharacterized. Here, we sought to investigate the function and mechanisms of the transfer RNA (tRNA) N7-methylguanosine (m7 G) modification in regulating the occurrence and development of HNSCC.METHODS: Cell lost-of-function and gain-of-function assays, xenograft models, conditional knockout and knockin mouse models were used to study the physiological functions of tRNA m7 G modification in HNSCC tumorigenesis. tRNA modification and expression profiling, mRNA translation profiling and rescue assays were performed to uncover the underlying molecular mechanisms. Single-cell RNA sequencing (scRNA-seq) was conducted to explore the tumor microenvironment changes.RESULTS: The tRNA m7 G methyltransferase complex components Methyltransferase-like 1 (METTL1)/WD repeat domain 4 (WDR4) were upregulated in HNSCC and associated with a poor prognosis. Functionally, METTL1/WDR4 promoted HNSCC progression and metastasis in cell-based and transgenic mouse models. Mechanistically, ablation of METTL1 reduced the m7 G levels of 16 tRNAs, inhibiting the translation of a subset of oncogenic transcripts, including genes related to the phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway. In addition, chemical modulators of the PI3K/Akt/mTOR signaling pathway reversed the effects of Mettl1 in mouse HNSCC. Furthermore, scRNA-seq results revealed that Mettl1 knockout in mouse tumor cells altered the immune landscape and cell-cell interaction between the tumor and stromal compartment.CONCLUSIONS: The tRNA m7 G methyltransferase METTL1 was found to promote the development and malignancy of HNSCC through regulating global mRNA translation, including the PI3K/AKT/mTOR signaling pathway, and found to alter immune landscape. METTL1 could be a promising treatment target for HNSCC patients.

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth

METTL5, an 18S Rrna-Specific M6a Methyltransferase, Modulates Expression of Stress Response Genes

N6-methyladenosine (m6a) in 18S Rrna Promotes Fatty Acid Metabolism and Oncogenic Transformation.

The M(6)a Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.

METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis

mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis

Critical Roles of METTL3 in Translation Regulation of Cancer

METTL16 Promotes Translation and Lung Tumorigenesis by Sequestering Cytoplasmic Eif4e2

The 18S rRNA m 6 A methyltransferase METTL 5 promotes mouse embryonic stem cell differentiation

METTL3 Preferentially Enhances Non-M6a Translation of Epigenetic Factors and Promotes Tumourigenesis

Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.

METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression

N6 -Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis

Methyltransferase-like Proteins in Cancer Biology and Potential Therapeutic Targeting

m3C32 tRNA modification controls serine codon-biased mRNA translation, cell cycle, and DNA-damage response

Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression

METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer

RNA M6a Methylation Regulates Dissemination of Cancer Cells by Modulating Expression and Membrane Localization of Β-Catenin.

SUMOylation of the M6a-Rna Methyltransferase METTL3 Modulates Its Function.